APGE CLUSTER SEC Filing Analysis

Latest settled — T+5d

APGE ▲ +5.16% at T+5d

NEUTRAL call ✓ call won +5.16% · α vs SPY +3.54% · entry $78.75 → $82.81

Next anchor: T+20d in 2h

Last close $88.33 (close Jun 12) · +12.17% from $78.75 entry

Entry anchored
May 15, 2026
via day open

T+1d

-0.61%

call -0.61% · α +0.04%

$78.27

settled 28d ago

T+5d

+5.16%

call +5.16% · α +3.54%

$82.81

settled 24d ago

T+20d

—

call — · α —

—

in 2h

T+60d

—

call — · α —

—

in 8w

Price Chart

Loading chart...

Executive Summary

CEO Michael Thomas Henderson sold $1.53M worth of APGE stock on May 13, 2026, and CMO Carl Dambkowski sold $311K on May 6, totaling $1.84M in insider sales. This cluster follows the company's Q1 2026 earnings release (net loss widened to $74.1M) and a $403M public offering. The sales represent ~0.03% of APGE's $6.3B market cap, a trivial amount, and are likely liquidity-driven post-offering rather than signaling bearish conviction.

Key Financial Metrics

Direction

selling

Total Value

$1.8M

Insiders

2

Actionable Insight

The insider sales are too small to be informative. Monitor for any insider buying or material pipeline catalysts (APEX Phase 2 data) that could move the stock. The strong cash runway and bullish analyst consensus suggest the recent offering was well-received.

Key Facts

CEO Henderson sold 18,659 shares at $82.05 for $1.53M on May 13, 2026.
CMO Dambkowski sold 3,700 shares at $83.92 for $311K on May 6, 2026.
Total insider sales of $1.84M represent ~0.03% of APGE's $6.3B market cap.
Sales occurred 2-9 days after Q1 2026 earnings (net loss $74.1M, wider than $55.3M YoY) and a $403M public offering.
APGE has a strong cash position of $1.3B, extending runway into 2029.
Analyst consensus is 83% bullish (19 Buy/10 Strong Buy, 4 Hold).

Financial Impact

Insider sales of $1.84M are trivial relative to $6.3B market cap (0.03%). No material financial impact.

dilution

Risk Factors

Widening net loss trajectory (Q1 2026 loss of $74.1M vs. $55.3M YoY) could pressure cash burn if pipeline milestones are delayed.
Potential for further dilutive offerings if cash needs increase beyond 2029 runway.
Insider selling pattern, while small, may continue post-offering.

Market Snapshot

Exchange

Nasdaq

Sector

Biological Products, (No Diagnostic Substances)

Analyst Consensus

83% bullish (23 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

Document	Accession Number
CLUSTER Data (Synthetic)	cluster-APGE-1778889642156

19 reports for APGE

T+1T+5T+20T+60

70% Hit rate 7 of 10 directional calls best @ T+20▲ +14.66%Mar 23, 2026

Filters

Reports for APGE — sortable, filterable
	Type				Now
May 27, 2026 18d ago	8-K BULLISH ★ 7/10	$77.75 $78.71	▲ +1.23%	▲ +0.03%	$88.33 (+13.61%)
May 27, 2026 18d ago	8-K BULLISH ★ 7/10	$77.75 $78.71	▲ +1.23%	▲ +0.03%	$88.33 (+13.61%)
May 27, 2026 18d ago	Press Release BULLISH ★ 7/10	$77.75 $78.71	▲ +1.23%	▲ +0.03%	$88.33 (+13.61%)
May 27, 2026 18d ago	Press Release BULLISH ★ 8/10	$77.75 $78.71	▲ +1.23%	▲ +0.03%	$88.33 (+13.61%)
May 26, 2026 19d ago	Press Release NEUTRAL ★ 6/10	$77.75 $78.71	▲ +1.23%	▲ +0.03%	$88.33 (+13.61%)
May 16, 2026 4w ago	Insider Cluster NEUTRAL ★ 3/10	$78.75 $82.81	▲ +5.16%	▲ +3.54%	$88.33 (+12.17%)
May 13, 2026 4w ago	144 NEUTRAL ★ 2/10	$83.94 $81.39	▼ −3.04%	▼ −2.90%	$88.33 (+5.23%)
May 11, 2026 4w ago	8-K BULLISH ★ 7/10	$84.60 $78.75	▼ −6.91%	▼ −6.83%	$88.33 (+4.41%)
May 11, 2026 4w ago	Press Release BULLISH ★ 7/10	$84.60 $78.75	▼ −6.91%	▼ −6.83%	$88.33 (+4.41%)
May 1, 2026 6w ago	Insider Cluster NEUTRAL ★ 2/10	$80.75 $83.03	▲ +2.82%	▲ +0.48%	$88.33 (+9.39%)

US Market Status

Market Closed — Opens in 3h 51m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access